ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S
July 04, 2018NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 million extension of the Series B round. Together with an earlier CHF 20 million series B fin
Pharma Sources Insight January 2025
